• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: David Chiswell     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: personyago:WikicatLivingPeopleyago:CausalAgent100007347yago:LivingThing100004258yago:Object100002684yago:Organism100004475yago:Person100007846yago:PhysicalEntity100001930yago:YagoLegalActoryago:YagoLegalActorGeoyago:Whole100003553 New Facet based on Instances of this Class

David Chiswell OBE is a British business executive and scientist who co-founded Cambridge Antibody Technology, a biosciences company in operation from 1990 to 2007. The company was an early innovator that pioneered the development of antibody drugs, including adalimumab, used in the treatment of rheumatoid arthritis among other things. CAT was described by The Independent newspaper as "the jewel in the crown of UK biotech." From 1990 to 2002, Chiswell was operationally responsible for running CAT. From 1996 until 2002, Chiswell was the company's CEO. After he left CAT he devoted himself to growing the British biosciences industry, serving as the chairman of the BioIndustry Association from 2003 to 2005.